PLENTI

Welcome to the Brand page for “PLENTI”, which is offered here for Clinical medical reagents for use in gene therapy, pharmaceutical preparations for use in gene therapy,enzymes and enzyme preparations for medical purpose, for use in gene delivery and cloning technology, retroviral vector and retroviral vector manufacturing preparations for use in gene delivery and cloning technology;chemicals for use in the manufacture of viruses, vectors, pharmaceuticals and retroviral vector preparations for use in industry, science and medical science; enzymes and chemical products for in vitro use in laboratories and for analysis in and development of gene delivery technology; micro organisms, cell cultures, plasmids and cultures of micro organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic acid and variations thereof, all for in vivo or ex vivo use in gene delivery technology and cloning technology;medical services;scientific and medical research and development, and product development; genetic engineering services, biotechnology services, research and development of new products for others in the field of gene technology and gene therapy;.

Its status is currently believed to be active. Its class is unavailable. “PLENTI” is believed to be currently owned by “Oxford BioMedica plc”.